Ray Valencia, vice president of Clinical at Sensyne Health tells readers of the four key trends expected to impact life sciences and pharma this year.
2021 was a significant year for the advancement of healthcare, perhaps even more so than when the pandemic first hit the entire global population in 2020. Since the first SARS-CoV-2 vaccination programme started, over half of the globe is now fully vaccinated, with the extra protection of a third ‘booster’ jab currently being rolled out.
There is no doubt that the pandemic is still causing suffering, but it has also triggered a shift within the entire health system and exposed the urgent need for innovation in how treatments are discovered, and care is provided. Over the last year, we’ve seen huge strides taken, for example, the need to remotely interact with healthcare providers; the use of advanced predictive algorithms to predict disease deterioration, and the acceleration of vaccine and drug development.